Fountain Therapeutics

Developing first-in-class therapies for aging-related diseases and conditions

placeSan Francisco, California, United States calendar_todayFounded 2018 groups17 employees language fountaintx.com

Registered entities

Investor mix

5 investors on record; lead investors include Khosla Ventures, Nan Fung Life Sciences.

Investor typeCountShare
Venture capital240%
Bank & private debt120%
Other / undisclosed240%
Coming soon